Vistagen meets ICH safety exposure standards for fasedienol trials

Go back to Vistagen meets ICH safety exposure standards for fasedienol trials
(NASDAQ: VTGN) Delayed: 0.64 --0 (-0%)
Previous Close $0.64    52 Week High $4.60 
Open $0.64    52 Week Low $2.81 
Day High $0.64    P/E N/A 
Day Low $0.64    EPS $0.00 
Volume 2,369